Procter & Gamble Health Ltd EPS
Procter & Gamble Health Ltd
NSE: PGHL
EPS
Key Highlights
- The Earning per Share of Procter & Gamble Health Ltd is ₹ 200.73 as of 30 Oct 26 The earning per share of Procter & Gamble Health Ltd changed from ₹ 28 to ₹ 57.92 over 8 quarters. This represents a CAGR of 43.83% .
Historical Earning per Share of Procter & Gamble Health Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
Historical Earning per Share of Procter & Gamble Health Ltd
Company Fundamentals for Procter & Gamble Health Ltd
Market Cap
9,435 Cr
EPS
200.7
P/E Ratio (TTM)
28.3
P/B Ratio (TTM)
18.0
Day’s High
5713.1
Day’s Low
5452.45
DTE
0.0
ROE
62.3
52 Week High
6955.0
52 Week Low
4699.7
ROCE
84.1
Market Price of Procter & Gamble Health Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 30 Oct 2026 | 5684.4 |
| 29 Oct 2026 | 5510.6 |
| 28 Oct 2026 | 5396.05 |
| 27 Oct 2026 | 5524.95 |
| 26 Oct 2026 | 5054.2 |
| 23 Oct 2026 | 5032.75 |
| 22 Oct 2026 | 5066.65 |
| 21 Oct 2026 | 5049.65 |
| 19 Oct 2026 | 5122.75 |
| 16 Oct 2026 | 5205.85 |
SWOT Analysis Of Procter & Gamble Health Ltd
BlinkX Score for Procter & Gamble Health Ltd
Asset Value vs Market Value of Procter & Gamble Health Ltd
Market Value
₹ 9,436
Asset Value
Value addition
15.1 X
₹ 587
* All values are in ₹ crores
Competitive Comparison of EPS
| Company | Market Cap | EPS |
|---|
Procter & Gamble Health Ltd | 9435 | 200.73 |
Sun Pharmaceutical Industries Ltd | 426662 | 51.3 |
Divis Laboratories Ltd | 257903 | 112.23 |
Torrent Pharmaceuticals Ltd | 176306 | 57.08 |
Laurus Labs Ltd | 129243 | 24.8 |
Zydus Lifesciences Ltd | 124089 | 48.95 |
| Company | |
|---|---|
| Procter & Gamble Health Ltd | 9435 |
| Sun Pharmaceutical Industries Ltd | 426662 |
| Divis Laboratories Ltd | 257903 |
| Torrent Pharmaceuticals Ltd | 176306 |
| Laurus Labs Ltd | 129243 |
| Zydus Lifesciences Ltd | 124089 |
Historical Market Cap of Procter & Gamble Health Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Procter & Gamble Health Ltd
Historical Revenue of Procter & Gamble Health Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Procter & Gamble Health Ltd
Historical EBITDA of Procter & Gamble Health Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Procter & Gamble Health Ltd
Historical Net Profit of Procter & Gamble Health Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Procter & Gamble Health Ltd
Dividend Payout Over Time
Procter & Gamble Health Ltd News Hub
P&G Health slides as Q4 PAT drops 44% YoY to Rs 17 cr
Revenue from operations slipped 5.74% year on year to Rs 283.88 crore during the quarter, owing to c
Read more
22 Aug 24
Board of Procter & Gamble Health recommends final dividend
Procter & Gamble Health announced that the Board of Directors of the Company at its meeting held on
Read more
21 Aug 24
Procter & Gamble Health to pay final dividend
Procter & Gamble Health announced that final dividend of Rs 60 per share for FY 2024 will be paid by
Read more
21 Aug 24
Broader market outperforms; European mkt opens higher
The headline equity indices traded with decent gains in afternoon trade. The Nifty hovered above the
Read more
22 Aug 24
